Cardiovascular News: Breaking Cardiovascular News, Comments and Articles. - Page: 5

One Year Data from St. Jude Medical Study Demonstrates Safe, Rapid and Sustained Blood Pressure Reduction with EnligHTN Renal Denervation Technology

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced that the company’s EnligHTN™ Multi-Electrode Renal Denervation System provides a safe, rapid and sustained reduction in blood pressure measurements after one year. The new one year study data from the EnligHTN I trial was presented today at EuroPCR 2013 in Paris.

Fish oil may counteract the detrimental effects of mental stress on heart

The omega 3 fatty acids in fish oil have long been thought to protect against cardiovascular disease-so much so that the American Heart Association currently recommends eating at least two servings of fish a week, particularly fatty varieties rich in...

El Paso Children's Hospital Standardizes to Masimo SET® Pulse Oximetry

EL PASO, Texas and IRVINE, Calif., May 23, 2013 /PRNewswire/ -- Masimo (NASDAQ: MASI) today announced that El Paso Children's Hospital, the newest and most expansive dedicated children's hospital in west Texas,has upgraded to Masimo SET® pulse oximetry and sensor technologies, the standard-of-care at leading health organizations worldwide. Masimo SET® pulse oximetry has been s...

Zensun Announces Positive Clinical Results for Neucardin™ to Improve Heart Function and Reduce Mortality in Chronic Heart Failure Patients

SAN DIEGO and SHANGHAI, May 23, 2013 /PRNewswire/ -- Zensun Sci & Tech, Ltd., a biopharmaceutical company based in Shanghai and San Diego, announced today positive results of four completed Phase 2 clinical trials including three double-blind, placebo-controlled studies conducted in China and Australia and interim results from the United States Phase 2 trial for Zensun's in...

Medtronic's In.Pact Falcon Drug-Eluting Balloon Yields Positive Outcomes in Small Coronary Arteries

Presented at EuroPCR, One-Year Data from BELLO Study Show Durability of Clinical Results Following Treatment of De Novo Lesions with Novel Angioplasty Device PARIS -- May 23, 2013 -- One-year data from an Italian multicenter randomized controlled trial of the IN.PACT Falcon drug-eluting balloon from Medtronic, Inc. (NYSE: MDT) demonstrate positive and durable clinical results with the novel ang...

Innovative medication to shatter blood clots with light

Earthquakes, snakes, forest fires – none rob humans of life more frequently than the tiny clumps of fat, calcium and cholesterol we know as blood clots. Every fifth human dies when a blood clot, or more correctly cholesterol plaque, loosens and get...

Isis Pharmaceuticals to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference

CARLSBAD, Calif., May 23, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at the Deutsche Bank 38th Annual dbAccess Health Care Conference on Thursday, May 30, 2013 at 8:40 a.m. ET in Boston, MA. A live audio webcast of the presentation will be available on the "Investors & Me...

More Baby Boomers Rejected by Long Term Care Insurance Companies

LTC Tree, the number one “virtual” seller of Long Term Care Insurance in the industry, has launched a Health and Wellness section on their website designed to help clients reduce the risk that they will need to use their Long Term Care Insurance policy. LTC Tree Health provides the latest research and information on nutrition, fitness, mental health, and aging to encourage consumers to make he...

Cardiologist Density and Outcomes

Patients who have an MI or develop heart failure in a part of the country with a low density of practicing cardiologists have a slightly higher risk of death at 30 days and one year compared with those who have the same clinical events in an area...

Glasgow Science Centre Features SynCardia Total Artificial Heart in $3 Million Exhibition

TUCSON, Ariz., May 23, 2013 /PRNewswire/ -- SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that the Glasgow Science Centre in Scotland, which boasts more than 380,000 visitors annually, is featuring the SynCardia temporary Total Artificial Heart powered by the Fr...

One Nucleus signs agreement with Bionow to expand access to One Nucleus preferred suppliers

One Nucleus is delighted to announce that an agreement has been signed with Bionow for their Premium Members to have access to the One Nucleus Preferred Suppliers through the One Nucleus Purchasing Consortium Scheme. This agreement took effect on 1 J...

InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group

PARIS, May 23, 2013 /PRNewswire/ -- InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), the leader in embolic protection stents, today announced new 6-month results from the MASTER (MGuard for Acute ST Elevation Reperfusion) trial demonstrating that the MGuard Embolic Protection Stent (EPS) outperformed bare metal and drug eluting stents in all-cause mortality in ST segment elevation...

Nordion Enters into Agreement to Divest Targeted Therapies Business to BTG plc

Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services for the prevention, diagnosis and treatment of disease, announced that it has entered into an agreement to divest its Targeted Therapies business to BTG plc (LSE: BTG) (“BTG”), an international specialist healthcare company based in London, United Kingdom, for a cash purc...

Immune system attacks beneficial bacteria in several chronic human diseases

The human gut is loaded with commensal bacteria - "good" microbes that, among other functions, help the body digest food. The gastrointestinal tract contains literally trillions of such cells, and yet the immune system seemingly turns a blind eye. Ho...

CardioKinetix reports meta-analysis study results of Parachute Ventricular Partitioning Device

CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced results of a meta-analysis study of the first-of-its-kind catheter-based Parachute Ventricular Partitioning Device. Six-month clinic...

Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013

SAN DIEGO and PARIS, May 23, 2013 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced preliminary results from the ADVISE (Adenosine Vasodilator Independent Stenosis Evaluation) II trial during the hot line late bre...

hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Safe and Healthy New Fast Weight Loss Alternative for At-Risk Heart Disease Patients

Charlotte, NC (PRWEB) May 23, 2013 According to the Centers for Disease Control, heart disease has become the number one cause of death in America today and is the leading cause of death in women over 40 years old. More than 400,000 women die in...

Cedars-Sinai Heart Institute honors Alain Carpentier with Corday Prize

Cedars-Sinai Heart Institute is honoring the physician widely known as the leading pioneer in modern mitral heart valve repair, Alain Carpentier, MD, PhD, with the second annual Eliot Corday, MD, International Prize in Heart Research.

Health officials discuss new strategies to prevent rheumatic fever, rheumatic heart disease

Today, at the World Health Assembly, top health officials from New Zealand, South Africa, Australia, Fiji and Rwanda met to discuss the vital need for countries to integrate rheumatic fever and rheumatic heart disease prevention and control into nati...

American Clinical Solutions Adds Ritalin to Their Drug Test Panel

Boca Raton, FL, May 23, 2013 --(PR.com)-- American Clinical Solutions now offers drug tests for both methylphenidate and ritalinic acid in urinary or oral fluid samples. Ritalin (methylphenidate) is the most commonly prescribed drug for attention deficit hyperactivity disorder (ADHD), a major neurobehavioral disorder in childhood. ADHD is characterized by hyperactivity, limited attention span, an...

Study explains gender differences in the impact of OSA on cardiovascular disease, mortality

A new study from researchers in Japan indicates that obstructive sleep apnea is independently associated with visceral (abdominal) fat accumulation only in men, perhaps explaining gender differences in the impact of OSA on cardiovascular disease and...

Patients At Risk Of Heart Disease Set To Benefit From Clinical Trial

Patients suffering from high blood pressure - the single most important risk for death worldwide - could be helped by a UK-wide clinical trial aimed at improving treatments. Clinicians have recruited the 500th patient to the trial, which is evaluatin...

Walk This Way

There are countless physical activities out there, but walking has the lowest dropout rate of them all and is one of the most basic changes you can make to effectively improve your heart health By The American Heart Association Not fast enough. Not...

At HRS, Topera Topples Conventional Wisdom About Atrial Fibrillation

Topera Medical questions the assumptions underlying current therapies for atrial fibrillation. Sanjiv Narayan, MD, PhD, the electrophysiologist who founded Topera, has developed a means of identifying focal sources of aberrant electrical activity cal...

Edwards’ Success With Go-Slow Sapien Launch

Transcatheter heart valves (TAVI) arrived in Europe in 2007 with the introduction of Medtronic Inc.’s CoreValve, followed shortly thereafter by Edwards Lifesciences Corp.’s Sapien. (See"CoreValve: A Surgeon Moves Heart Valves to the Cath Lab" —...